Company / Financials
ATOSSA THERAPEUTICS, INC. Financials
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$1.8K
FY2016 · -95.6% YoY
Net Income
-$15.8M
FY2016 · -7.5% YoY
Profit Margin
-896491.6%
FY2016 · net income / revenue
ROE
-165.9%
FY2016 · return on equity
Total Assets
$6.2M
FY2016
Total Debt
-
FY2016
Equity
$9.5M
FY2016
ROA
-252.4%
FY2016 · return on assets
Statement paths
Financial highlights
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$1.8K-95.6% YoYNet Income HistoryProfit after all expenses and taxes-$15.8M-7.5% YoYGross Profit HistoryRevenue minus cost of goods sold-$130.7K-425.5% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$132.4KOperating Income HistoryProfit from core business operations before interest and taxes-$12.8M-4.8% YoYSG&A Expense HistorySelling, general, and administrative expenses$8.8M+9.9% YoYR&D Expense HistoryResearch and development spending$2.4M+112.5% YoYInterest Expense HistoryCost of borrowing and debt obligations$360Income Tax HistoryTotal income tax expense$0EPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$8.31-1262.3% YoY